The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS).

Green Mediterranean diet age-related atrophy aging dietary intervention hippocampal occupancy score neurodegeneration polyphenols

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 12 09 2021
accepted: 08 01 2022
pubmed: 13 1 2022
medline: 10 5 2022
entrez: 12 1 2022
Statut: ppublish

Résumé

The effect of diet on age-related brain atrophy is largely unproven. We aimed to explore the effect of a Mediterranean diet (MED) higher in polyphenols and lower in red/processed meat (Green-MED diet) on age-related brain atrophy. This 18-mo clinical trial longitudinally measured brain structure volumes by MRI using hippocampal occupancy score (HOC) and lateral ventricle volume (LVV) expansion score as neurodegeneration markers. Abdominally obese/dyslipidemic participants were randomly assigned to follow 1) healthy dietary guidelines (HDG), 2) MED, or 3) Green-MED diet. All subjects received free gym memberships and physical activity guidance. Both MED groups consumed 28 g walnuts/d (+440 mg/d polyphenols). The Green-MED group consumed green tea (3-4 cups/d) and Mankai (Wolffia-globosa strain, 100 g frozen cubes/d) green shake (+800 mg/d polyphenols). Among 284 participants (88% men; mean age: 51 y; BMI: 31.2 kg/m2; APOE-ε4 genotype = 15.7%), 224 (79%) completed the trial with eligible whole-brain MRIs. The pallidum (-4.2%), third ventricle (+3.9%), and LVV (+2.2%) disclosed the largest volume changes. Compared with younger participants, atrophy was accelerated among those ≥50 y old (HOC change: -1.0% ± 1.4% compared with -0.06% ± 1.1%; 95% CI: 0.6%, 1.3%; P < 0.001; LVV change: 3.2% ± 4.5% compared with 1.3% ± 4.1%; 95% CI: -3.1%, -0.8%; P = 0.001). In subjects ≥ 50 y old, HOC decline and LVV expansion were attenuated in both MED groups, with the best outcomes among Green-MED diet participants, as compared with HDG (HOC: -0.8% ± 1.6% compared with -1.3% ± 1.4%; 95% CI: -1.5%, -0.02%; P = 0.042; LVV: 2.3% ± 4.7% compared with 4.3% ± 4.5%; 95% CI: 0.3%, 5.2%; P = 0.021). Similar patterns were observed among younger subjects. Improved insulin sensitivity over the trial was the parameter most strongly associated with brain atrophy attenuation (P < 0.05). Greater Mankai, green tea, and walnut intake and less red and processed meat were significantly and independently associated with reduced HOC decline (P < 0.05). Elevated urinary concentrations of the polyphenols urolithin-A (r = 0.24; P = 0.013) and tyrosol (r = 0.26; P = 0.007) were significantly associated with lower HOC decline. A Green-MED (high-polyphenol) diet, rich in Mankai, green tea, and walnuts and low in red/processed meat, is potentially neuroprotective for age-related brain atrophy.This trial was registered at clinicaltrials.gov as NCT03020186.

Sections du résumé

BACKGROUND
The effect of diet on age-related brain atrophy is largely unproven.
OBJECTIVES
We aimed to explore the effect of a Mediterranean diet (MED) higher in polyphenols and lower in red/processed meat (Green-MED diet) on age-related brain atrophy.
METHODS
This 18-mo clinical trial longitudinally measured brain structure volumes by MRI using hippocampal occupancy score (HOC) and lateral ventricle volume (LVV) expansion score as neurodegeneration markers. Abdominally obese/dyslipidemic participants were randomly assigned to follow 1) healthy dietary guidelines (HDG), 2) MED, or 3) Green-MED diet. All subjects received free gym memberships and physical activity guidance. Both MED groups consumed 28 g walnuts/d (+440 mg/d polyphenols). The Green-MED group consumed green tea (3-4 cups/d) and Mankai (Wolffia-globosa strain, 100 g frozen cubes/d) green shake (+800 mg/d polyphenols).
RESULTS
Among 284 participants (88% men; mean age: 51 y; BMI: 31.2 kg/m2; APOE-ε4 genotype = 15.7%), 224 (79%) completed the trial with eligible whole-brain MRIs. The pallidum (-4.2%), third ventricle (+3.9%), and LVV (+2.2%) disclosed the largest volume changes. Compared with younger participants, atrophy was accelerated among those ≥50 y old (HOC change: -1.0% ± 1.4% compared with -0.06% ± 1.1%; 95% CI: 0.6%, 1.3%; P < 0.001; LVV change: 3.2% ± 4.5% compared with 1.3% ± 4.1%; 95% CI: -3.1%, -0.8%; P = 0.001). In subjects ≥ 50 y old, HOC decline and LVV expansion were attenuated in both MED groups, with the best outcomes among Green-MED diet participants, as compared with HDG (HOC: -0.8% ± 1.6% compared with -1.3% ± 1.4%; 95% CI: -1.5%, -0.02%; P = 0.042; LVV: 2.3% ± 4.7% compared with 4.3% ± 4.5%; 95% CI: 0.3%, 5.2%; P = 0.021). Similar patterns were observed among younger subjects. Improved insulin sensitivity over the trial was the parameter most strongly associated with brain atrophy attenuation (P < 0.05). Greater Mankai, green tea, and walnut intake and less red and processed meat were significantly and independently associated with reduced HOC decline (P < 0.05). Elevated urinary concentrations of the polyphenols urolithin-A (r = 0.24; P = 0.013) and tyrosol (r = 0.26; P = 0.007) were significantly associated with lower HOC decline.
CONCLUSIONS
A Green-MED (high-polyphenol) diet, rich in Mankai, green tea, and walnuts and low in red/processed meat, is potentially neuroprotective for age-related brain atrophy.This trial was registered at clinicaltrials.gov as NCT03020186.

Identifiants

pubmed: 35021194
pii: S0002-9165(22)00250-7
doi: 10.1093/ajcn/nqac001
pmc: PMC9071484
doi:

Substances chimiques

Polyphenols 0
Tea 0

Banques de données

ClinicalTrials.gov
['NCT03020186']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1270-1281

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Public Health Nutr. 2004 Sep;7(6):745-9
pubmed: 15369612
Neuroimage. 2010 Jul 1;51(3):943-51
pubmed: 20211265
Eur J Nutr. 2019 Feb;58(1):113-130
pubmed: 29151137
Hum Brain Mapp. 2018 Jun;39(6):2500-2513
pubmed: 29468773
J Clin Med. 2020 Mar 19;9(3):
pubmed: 32204500
Am J Geriatr Psychiatry. 2015 May;23(5):456-65
pubmed: 25306196
Diabetes Care. 2016 May;39(5):764-71
pubmed: 27208378
Neurochem Int. 2015 Oct;89:157-69
pubmed: 25959627
Neurobiol Aging. 2012 May;33(5):845-55
pubmed: 20855131
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
J Nutr. 2005 Mar;135(3):573-9
pubmed: 15735096
Nat Rev Neurosci. 2010 May;11(5):339-50
pubmed: 20354534
Obesity (Silver Spring). 2008 Jan;16(1):119-24
pubmed: 18223623
Front Neurosci. 2020 Aug 12;14:786
pubmed: 32903442
Database (Oxford). 2013 Oct 07;2013:bat070
pubmed: 24103452
Am J Clin Nutr. 2018 Mar 1;107(3):389-404
pubmed: 29566197
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Nutr Neurosci. 2019 Mar;22(3):185-195
pubmed: 28784051
Nutr Diabetes. 2018 Mar 9;8(1):13
pubmed: 29549354
Alzheimers Dement. 2018 Jul;14(7):902-912
pubmed: 29605385
Clin Nutr. 2019 Dec;38(6):2576-2582
pubmed: 30591380
Arch Neurol. 2005 Oct;62(10):1556-60
pubmed: 16216938
Behav Res Methods. 2019 Feb;51(1):40-60
pubmed: 30022459
Ann Neurol. 2016 Jun;79(6):1014-25
pubmed: 27129740
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283806
Am J Clin Nutr. 2010 Oct;92(4):801-9
pubmed: 20810980
Rev Neurosci. 2019 Dec 18;31(1):1-57
pubmed: 31194693
Bull Exp Biol Med. 2019 Dec;168(2):224-228
pubmed: 31776958
Neurology. 2015 Nov 17;85(20):1744-51
pubmed: 26491085
BMC Geriatr. 2019 Feb 28;19(1):59
pubmed: 30819102
J Nutr. 2019 Jun 1;149(6):1004-1011
pubmed: 30915471
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Neurology. 2013 Sep 3;81(10):904-9
pubmed: 23925758
J Neuropsychiatry Clin Neurosci. 2015;27(2):147-52
pubmed: 25923853
Nutrients. 2021 May 30;13(6):
pubmed: 34070816
Neurology. 2011 Oct 25;77(17):1619-28
pubmed: 21998317
Neuroimage Clin. 2019;23:101904
pubmed: 31254939
Assessment. 2022 Jun;29(4):717-730
pubmed: 33522278
Neurology. 2017 Jan 31;88(5):449-455
pubmed: 28053008
Gut. 2021 Nov;70(11):2085-2095
pubmed: 33461965
Mol Aspects Med. 2012 Feb;33(1):83-97
pubmed: 22107709
Epidemiology. 1996 Jan;7(1):81-6
pubmed: 8664406
AJNR Am J Neuroradiol. 2000 Jan;21(1):112-8
pubmed: 10669234
Nature. 1971 Aug 13;232(5311):495
pubmed: 4937216
Am J Clin Nutr. 2020 Mar 1;111(3):590-600
pubmed: 31912155
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22
pubmed: 21282661
Nutrients. 2020 Feb 20;12(2):
pubmed: 32093220
J Am Coll Cardiol. 2020 May 26;75(20):2525-2534
pubmed: 32439001
Rejuvenation Res. 2009 Dec;12(6):445-53
pubmed: 20041738
J Neuroinflammation. 2019 Mar 14;16(1):62
pubmed: 30871577
Oxid Med Cell Longev. 2012;2012:541971
pubmed: 22829957
Circulation. 2018 Mar 13;137(11):1143-1157
pubmed: 29142011
Diabetes Care. 2019 Jul;42(7):1162-1169
pubmed: 31076421
Am J Epidemiol. 2007 Jun 15;165(12):1364-71
pubmed: 17369607

Auteurs

Alon Kaplan (A)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Hila Zelicha (H)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Anat Yaskolka Meir (A)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ehud Rinott (E)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Gal Tsaban (G)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Soroka University Medical Center, Beer-Sheva, Israel.

Gidon Levakov (G)

Department of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ofer Prager (O)

Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Moti Salti (M)

Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Yoram Yovell (Y)

Department of Medical Neurobiology, The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel.

Jonathan Ofer (J)

Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Sebastian Huhn (S)

Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany.

Frauke Beyer (F)

Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Veronica Witte (V)

Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Arno Villringer (A)

Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Nachshon Meiran (N)

Department of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Tamar B Emesh (T)

Department of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Peter Kovacs (P)

Integrated Research and Treatment Center (IFB) Adiposity Diseases, Leipzig University Medical Center, Leipzig, Germany.

Martin von Bergen (M)

Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany.

Uta Ceglarek (U)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.

Matthias Blüher (M)

Department of Medicine, Leipzig University, Leipzig, Germany.

Michael Stumvoll (M)

Department of Medicine, Leipzig University, Leipzig, Germany.

Frank B Hu (FB)

Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
Department of Medicine, Harvard Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Meir J Stampfer (MJ)

Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
Department of Medicine, Harvard Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Alon Friedman (A)

Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Ilan Shelef (I)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Soroka University Medical Center, Beer-Sheva, Israel.

Galia Avidan (G)

Department of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Iris Shai (I)

The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH